25.68 USD
-0.16 (-0.62%)
25.68 USD
0 (0%)
Overall PGNY gets a fundamental rating of 7 out of 10. We evaluated PGNY against 101 industry peers in the Health Care Providers & Services industry. PGNY scores excellent points on both the profitability and health parts. This is a solid base for a good stock. PGNY is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make PGNY suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
PGNY had positive earnings in the past year.
PGNY had a positive operating cash flow in the past year.
In the past 5 years PGNY has always been profitable.
Each year in the past 5 years PGNY had a positive operating cash flow.
1.2 Ratios
PGNY's Return On Assets of 7.11% is amongst the best of the industry. PGNY outperforms 88.12% of its industry peers.
Looking at the Return On Equity, with a value of 10.10%, PGNY is in the better half of the industry, outperforming 71.29% of the companies in the same industry.
With an excellent Return On Invested Capital value of 11.24%, PGNY belongs to the best of the industry, outperforming 83.17% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for PGNY is in line with the industry average of 9.58%.
The 3 year average ROIC (8.25%) for PGNY is below the current ROIC(11.24%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.11% | ||
| ROE | 10.1% | ||
| ROIC | 11.24% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
1.3 Margins
With a decent Profit Margin value of 4.46%, PGNY is doing good in the industry, outperforming 77.23% of the companies in the same industry.
In the last couple of years the Profit Margin of PGNY has declined.
The Operating Margin of PGNY (6.77%) is better than 69.31% of its industry peers.
In the last couple of years the Operating Margin of PGNY has grown nicely.
Looking at the Gross Margin, with a value of 22.94%, PGNY is in line with its industry, outperforming 48.51% of the companies in the same industry.
In the last couple of years the Gross Margin of PGNY has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.77% | ||
| PM (TTM) | 4.46% | ||
| GM | 22.94% |
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
2. Health
2.1 Basic Checks
PGNY has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
PGNY has less shares outstanding than it did 1 year ago.
The number of shares outstanding for PGNY has been increased compared to 5 years ago.
There is no outstanding debt for PGNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
PGNY has an Altman-Z score of 8.55. This indicates that PGNY is financially healthy and has little risk of bankruptcy at the moment.
PGNY has a Altman-Z score of 8.55. This is amongst the best in the industry. PGNY outperforms 93.07% of its industry peers.
There is no outstanding debt for PGNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.55 |
ROIC/WACC1.24
WACC9.06%
2.3 Liquidity
A Current Ratio of 2.96 indicates that PGNY has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.96, PGNY belongs to the best of the industry, outperforming 84.16% of the companies in the same industry.
PGNY has a Quick Ratio of 2.96. This indicates that PGNY is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.96, PGNY belongs to the top of the industry, outperforming 84.16% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.96 |
3. Growth
3.1 Past
PGNY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.62%, which is quite good.
The Earnings Per Share has been decreasing by -4.77% on average over the past years.
Looking at the last year, PGNY shows a quite strong growth in Revenue. The Revenue has grown by 11.41% in the last year.
Measured over the past years, PGNY shows a very strong growth in Revenue. The Revenue has been growing by 38.42% on average per year.
EPS 1Y (TTM)8.62%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%36.36%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.32%
3.2 Future
PGNY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.94% yearly.
Based on estimates for the next years, PGNY will show a quite strong growth in Revenue. The Revenue will grow by 8.83% on average per year.
EPS Next Y17.75%
EPS Next 2Y38.5%
EPS Next 3Y32.43%
EPS Next 5Y32.94%
Revenue Next Year11.28%
Revenue Next 2Y10.4%
Revenue Next 3Y10.6%
Revenue Next 5Y8.83%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 40.76, PGNY can be considered very expensive at the moment.
PGNY's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 26.51. PGNY is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 23.49 indicates a rather expensive valuation of PGNY.
PGNY's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.13, PGNY is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.76 | ||
| Fwd PE | 23.49 |
4.2 Price Multiples
PGNY's Enterprise Value to EBITDA ratio is in line with the industry average.
82.18% of the companies in the same industry are more expensive than PGNY, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.44 | ||
| EV/EBITDA | 18.36 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PGNY has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as PGNY's earnings are expected to grow with 32.43% in the coming years.
PEG (NY)2.3
PEG (5Y)N/A
EPS Next 2Y38.5%
EPS Next 3Y32.43%
5. Dividend
5.1 Amount
PGNY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
25.68
-0.16 (-0.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.97%
Inst Owner Change7.39%
Ins Owners1.49%
Ins Owner Change0.8%
Market Cap2.21B
Revenue(TTM)1.27B
Net Income(TTM)56.57M
Analysts81.25
Price Target29.68 (15.58%)
Short Float %7.13%
Short Ratio3.53
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.43%
Min EPS beat(2)14.22%
Max EPS beat(2)14.63%
EPS beat(4)3
Avg EPS beat(4)8.02%
Min EPS beat(4)-11.77%
Max EPS beat(4)15%
EPS beat(8)5
Avg EPS beat(8)7.07%
EPS beat(12)9
Avg EPS beat(12)35.08%
EPS beat(16)13
Avg EPS beat(16)94.29%
Revenue beat(2)2
Avg Revenue beat(2)2.31%
Min Revenue beat(2)1.96%
Max Revenue beat(2)2.66%
Revenue beat(4)4
Avg Revenue beat(4)3.39%
Min Revenue beat(4)1.96%
Max Revenue beat(4)5.74%
Revenue beat(8)4
Avg Revenue beat(8)-0.43%
Revenue beat(12)7
Avg Revenue beat(12)0.39%
Revenue beat(16)9
Avg Revenue beat(16)-0.09%
PT rev (1m)1.12%
PT rev (3m)1.34%
EPS NQ rev (1m)0.39%
EPS NQ rev (3m)5.45%
EPS NY rev (1m)6.34%
EPS NY rev (3m)6.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.13%
Revenue NY rev (1m)1.4%
Revenue NY rev (3m)1.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.76 | ||
| Fwd PE | 23.49 | ||
| P/S | 1.75 | ||
| P/FCF | 11.44 | ||
| P/OCF | 10.64 | ||
| P/B | 3.95 | ||
| P/tB | 4.15 | ||
| EV/EBITDA | 18.36 |
EPS(TTM)0.63
EY2.45%
EPS(NY)1.09
Fwd EY4.26%
FCF(TTM)2.24
FCFY8.74%
OCF(TTM)2.41
OCFY9.4%
SpS14.72
BVpS6.5
TBVpS6.19
PEG (NY)2.3
PEG (5Y)N/A
Graham Number9.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.11% | ||
| ROE | 10.1% | ||
| ROCE | 14.68% | ||
| ROIC | 11.24% | ||
| ROICexc | 27.43% | ||
| ROICexgc | 30.82% | ||
| OM | 6.77% | ||
| PM (TTM) | 4.46% | ||
| GM | 22.94% | ||
| FCFM | 15.25% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
ROICexc(3y)19.18%
ROICexc(5y)17.15%
ROICexgc(3y)20.6%
ROICexgc(5y)18.86%
ROCE(3y)10.79%
ROCE(5y)10.01%
ROICexgc growth 3Y11.16%
ROICexgc growth 5Y-10.91%
ROICexc growth 3Y11.54%
ROICexc growth 5Y-2.19%
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
F-Score7
Asset Turnover1.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 330.21% | ||
| Cap/Sales | 1.16% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 230.54% | ||
| Profit Quality | 342.01% | ||
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.96 | ||
| Altman-Z | 8.55 |
F-Score7
WACC9.06%
ROIC/WACC1.24
Cap/Depr(3y)177.5%
Cap/Depr(5y)150.16%
Cap/Sales(3y)0.4%
Cap/Sales(5y)0.39%
Profit Quality(3y)290.66%
Profit Quality(5y)196.79%
High Growth Momentum
Growth
EPS 1Y (TTM)8.62%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%36.36%
EPS Next Y17.75%
EPS Next 2Y38.5%
EPS Next 3Y32.43%
EPS Next 5Y32.94%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.32%
Revenue Next Year11.28%
Revenue Next 2Y10.4%
Revenue Next 3Y10.6%
Revenue Next 5Y8.83%
EBIT growth 1Y31.12%
EBIT growth 3Y27.82%
EBIT growth 5Y41.01%
EBIT Next Year39.66%
EBIT Next 3Y20.34%
EBIT Next 5Y15.66%
FCF growth 1Y-2.78%
FCF growth 3Y93.67%
FCF growth 5YN/A
OCF growth 1Y2.69%
OCF growth 3Y90.18%
OCF growth 5YN/A
PROGYNY INC / PGNY FAQ
What is the fundamental rating for PGNY stock?
ChartMill assigns a fundamental rating of 7 / 10 to PGNY.
Can you provide the valuation status for PROGYNY INC?
ChartMill assigns a valuation rating of 4 / 10 to PROGYNY INC (PGNY). This can be considered as Fairly Valued.
How profitable is PROGYNY INC (PGNY) stock?
PROGYNY INC (PGNY) has a profitability rating of 7 / 10.
What is the earnings growth outlook for PROGYNY INC?
The Earnings per Share (EPS) of PROGYNY INC (PGNY) is expected to grow by 17.75% in the next year.